<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IPS Cell Therapy &#187; Molecular Genetics</title>
	<atom:link href="http://www.ipscelltherapy.net/category/molecular-genetics/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.ipscelltherapy.net</link>
	<description></description>
	<lastBuildDate>Sat, 31 Jul 2010 08:16:11 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Genetics research team discovers new recurrent translocations</title>
		<link>http://www.ipscelltherapy.net/genetics-research-team-discovers-new-recurrent-translocations-3/</link>
		<comments>http://www.ipscelltherapy.net/genetics-research-team-discovers-new-recurrent-translocations-3/#comments</comments>
		<pubDate>Sat, 31 Jul 2010 08:16:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/genetics-research-team-discovers-new-recurrent-translocations-3/</guid>
		<description><![CDATA[A genetics research team based at The Children&#8217;s Hospital of Philadelphia continues to discover recurrent translocationsplaces in which two chromosomes exchange pieces of themselves. As many as 1 in 600 persons carry balanced chromosome translocations, which involve no loss or gain of DNA. Most such people appear healthy, but may have a child with abnormal [...]]]></description>
			<content:encoded><![CDATA[<p>A genetics research team based at The Children&#8217;s Hospital of Philadelphia continues to discover recurrent translocationsplaces in which two chromosomes exchange pieces of themselves. As many as 1 in 600 persons carry balanced chromosome translocations, which involve no loss or gain of DNA. Most such people appear healthy, but may have a child with abnormal chromosome composition and &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/genetics-research-team-discovers-new-recurrent-translocations-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Researchers Find New Translocation; Weak Spots In DNA Lead To Genetic Disease</title>
		<link>http://www.ipscelltherapy.net/researchers-find-new-translocation-weak-spots-in-dna-lead-to-genetic-disease-2/</link>
		<comments>http://www.ipscelltherapy.net/researchers-find-new-translocation-weak-spots-in-dna-lead-to-genetic-disease-2/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 08:18:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/researchers-find-new-translocation-weak-spots-in-dna-lead-to-genetic-disease-2/</guid>
		<description><![CDATA[A genetics research team based at The Children&#8217;s Hospital of Philadelphia continues to discover recurrent translocationsplaces in which two chromosomes exchange pieces of themselves. As many as 1 in 600 persons carry balanced chromosome translocations, which involve no loss or gain of DNA. Most such people appear healthy, but may have a child with abnormal [...]]]></description>
			<content:encoded><![CDATA[<p>A genetics research team based at The Children&#8217;s Hospital of Philadelphia continues to discover recurrent translocationsplaces in which two chromosomes exchange pieces of themselves. As many as 1 in 600 persons carry balanced chromosome translocations, which involve no loss or gain of DNA. Most such people appear healthy, but may have a child with abnormal chromosome composition and &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/researchers-find-new-translocation-weak-spots-in-dna-lead-to-genetic-disease-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetics Redraws Marsupial Family Tree</title>
		<link>http://www.ipscelltherapy.net/genetics-redraws-marsupial-family-tree-2/</link>
		<comments>http://www.ipscelltherapy.net/genetics-redraws-marsupial-family-tree-2/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 08:18:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/genetics-redraws-marsupial-family-tree-2/</guid>
		<description><![CDATA[New analysis traces groups origins to South America.
]]></description>
			<content:encoded><![CDATA[<p>New analysis traces groups origins to South America.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/genetics-redraws-marsupial-family-tree-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Response Genetics, Inc. to Announce Second Quarter 2010 Financial Results</title>
		<link>http://www.ipscelltherapy.net/response-genetics-inc-to-announce-second-quarter-2010-financial-results-2/</link>
		<comments>http://www.ipscelltherapy.net/response-genetics-inc-to-announce-second-quarter-2010-financial-results-2/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 08:18:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/response-genetics-inc-to-announce-second-quarter-2010-financial-results-2/</guid>
		<description><![CDATA[LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce its financial results for this period in a press release to be issued before the market opens on Thursday, August 5, 2010. About Response Genetics, Inc. Response Genetics Inc. (RGI) is focused on [...]]]></description>
			<content:encoded><![CDATA[<p>LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce its financial results for this period in a press release to be issued before the market opens on Thursday, August 5, 2010. About Response Genetics, Inc. Response Genetics Inc. (RGI) is focused on the development &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/response-genetics-inc-to-announce-second-quarter-2010-financial-results-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Getting A Step Ahead Of Pathogens</title>
		<link>http://www.ipscelltherapy.net/getting-a-step-ahead-of-pathogens-2/</link>
		<comments>http://www.ipscelltherapy.net/getting-a-step-ahead-of-pathogens-2/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 08:17:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/getting-a-step-ahead-of-pathogens-2/</guid>
		<description><![CDATA[Genetic architecture and the evolution of RNA virusesIn biology and genetics, the concept of epistasis is what gives rise to the whole being more (or less) than the sum of its parts. The quantitative effect of a given mutation upon the traits of an organism has the potential to depend strongly upon the gene versions [...]]]></description>
			<content:encoded><![CDATA[<p>Genetic architecture and the evolution of RNA virusesIn biology and genetics, the concept of epistasis is what gives rise to the whole being more (or less) than the sum of its parts. The quantitative effect of a given mutation upon the traits of an organism has the potential to depend strongly upon the gene versions present in other parts of the genome, or even other mutations co-occurring in &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/getting-a-step-ahead-of-pathogens-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New tool for improving switchgrass</title>
		<link>http://www.ipscelltherapy.net/new-tool-for-improving-switchgrass/</link>
		<comments>http://www.ipscelltherapy.net/new-tool-for-improving-switchgrass/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 08:17:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/new-tool-for-improving-switchgrass/</guid>
		<description><![CDATA[Scientists have developed a new tool for deciphering the genetics of a native prairie grass being widely studied for its potential as a biofuel. The genetic map of switchgrass is expected to speed up the search for genes that will make the perennial plant a more viable source of bioenergy.
]]></description>
			<content:encoded><![CDATA[<p>Scientists have developed a new tool for deciphering the genetics of a native prairie grass being widely studied for its potential as a biofuel. The genetic map of switchgrass is expected to speed up the search for genes that will make the perennial plant a more viable source of bioenergy.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/new-tool-for-improving-switchgrass/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetics redraws marsupial family tree</title>
		<link>http://www.ipscelltherapy.net/genetics-redraws-marsupial-family-tree/</link>
		<comments>http://www.ipscelltherapy.net/genetics-redraws-marsupial-family-tree/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 08:17:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/genetics-redraws-marsupial-family-tree/</guid>
		<description><![CDATA[New analysis traces groups origins to South America
]]></description>
			<content:encoded><![CDATA[<p>New analysis traces groups origins to South America</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/genetics-redraws-marsupial-family-tree/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>American Society for Biochemistry and Molecular Biology honors 11 outstanding scientists</title>
		<link>http://www.ipscelltherapy.net/american-society-for-biochemistry-and-molecular-biology-honors-11-outstanding-scientists-2/</link>
		<comments>http://www.ipscelltherapy.net/american-society-for-biochemistry-and-molecular-biology-honors-11-outstanding-scientists-2/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 08:17:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/american-society-for-biochemistry-and-molecular-biology-honors-11-outstanding-scientists-2/</guid>
		<description><![CDATA[( American Society for Biochemistry and Molecular Biology ) The American Society for Biochemistry and Molecular Biology last week named 10 scientists the winners of the nonprofit&#8217;s annual awards. Another winner was announced earlier this year.
]]></description>
			<content:encoded><![CDATA[<p>( American Society for Biochemistry and Molecular Biology ) The American Society for Biochemistry and Molecular Biology last week named 10 scientists the winners of the nonprofit&#8217;s annual awards. Another winner was announced earlier this year.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/american-society-for-biochemistry-and-molecular-biology-honors-11-outstanding-scientists-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Speeding Up Diagnosis of Infectious Disease</title>
		<link>http://www.ipscelltherapy.net/speeding-up-diagnosis-of-infectious-disease-2/</link>
		<comments>http://www.ipscelltherapy.net/speeding-up-diagnosis-of-infectious-disease-2/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 08:19:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/speeding-up-diagnosis-of-infectious-disease-2/</guid>
		<description><![CDATA[A startup is developing sequencing-based tests that could detect infections within 24 hours. Current methods of diagnosing an infectious disease can take days to weeks. Now a Cambridge, MA-based startup called Pathogenica is developing a way to do it within a day&#8211;by reading the DNA sequence of pathogens.
]]></description>
			<content:encoded><![CDATA[<p>A startup is developing sequencing-based tests that could detect infections within 24 hours. Current methods of diagnosing an infectious disease can take days to weeks. Now a Cambridge, MA-based startup called Pathogenica is developing a way to do it within a day&#8211;by reading the DNA sequence of pathogens.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/speeding-up-diagnosis-of-infectious-disease-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Asuragen And Collaborators Report Results Using PCR-Only Technologies For The Comprehensive Molecular Assessment Of &#8230;</title>
		<link>http://www.ipscelltherapy.net/asuragen-and-collaborators-report-results-using-pcr-only-technologies-for-the-comprehensive-molecular-assessment-of/</link>
		<comments>http://www.ipscelltherapy.net/asuragen-and-collaborators-report-results-using-pcr-only-technologies-for-the-comprehensive-molecular-assessment-of/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 08:19:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/asuragen-and-collaborators-report-results-using-pcr-only-technologies-for-the-comprehensive-molecular-assessment-of/</guid>
		<description><![CDATA[Asuragen, Inc. announced the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods&#8230;
]]></description>
			<content:encoded><![CDATA[<p>Asuragen, Inc. announced the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/asuragen-and-collaborators-report-results-using-pcr-only-technologies-for-the-comprehensive-molecular-assessment-of/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A new tool for improving switchgrass</title>
		<link>http://www.ipscelltherapy.net/a-new-tool-for-improving-switchgrass/</link>
		<comments>http://www.ipscelltherapy.net/a-new-tool-for-improving-switchgrass/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 08:19:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/a-new-tool-for-improving-switchgrass/</guid>
		<description><![CDATA[( United States Department of Agriculture-Research, Education, and Economics ) Agricultural Research Service scientists have developed a new tool for deciphering the genetics of a native prairie grass being widely studied for its potential as a biofuel. The genetic map of switchgrass, published by Christian Tobias, a molecular biologist at the ARS Western Regional Research [...]]]></description>
			<content:encoded><![CDATA[<p>( United States Department of Agriculture-Research, Education, and Economics ) Agricultural Research Service scientists have developed a new tool for deciphering the genetics of a native prairie grass being widely studied for its potential as a biofuel. The genetic map of switchgrass, published by Christian Tobias, a molecular biologist at the ARS Western Regional Research Center in Albany &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/a-new-tool-for-improving-switchgrass/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gentris names UNC-CH professor as consulting medical director</title>
		<link>http://www.ipscelltherapy.net/gentris-names-unc-ch-professor-as-consulting-medical-director/</link>
		<comments>http://www.ipscelltherapy.net/gentris-names-unc-ch-professor-as-consulting-medical-director/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 08:19:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/gentris-names-unc-ch-professor-as-consulting-medical-director/</guid>
		<description><![CDATA[MORRISVILLE, N.C.  Karen Weck, director for Molecular Genetics at UNC-Chapel Hill, will work with Gentris Corporation as a consulting medical director.
]]></description>
			<content:encoded><![CDATA[<p>MORRISVILLE, N.C.  Karen Weck, director for Molecular Genetics at UNC-Chapel Hill, will work with Gentris Corporation as a consulting medical director.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/gentris-names-unc-ch-professor-as-consulting-medical-director/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A New Tool For Improving Switchgrass</title>
		<link>http://www.ipscelltherapy.net/a-new-tool-for-improving-switchgrass-2/</link>
		<comments>http://www.ipscelltherapy.net/a-new-tool-for-improving-switchgrass-2/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 08:19:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/a-new-tool-for-improving-switchgrass-2/</guid>
		<description><![CDATA[Agricultural Research Service (ARS) scientists have developed a new tool for deciphering the genetics of a native prairie grass being widely studied for its potential as a biofuel. The genetic map of switchgrass, published by Christian Tobias, a molecular biologist at the ARS Western Regional Research Center in Albany, Calif., and his colleagues, is expected [...]]]></description>
			<content:encoded><![CDATA[<p>Agricultural Research Service (ARS) scientists have developed a new tool for deciphering the genetics of a native prairie grass being widely studied for its potential as a biofuel. The genetic map of switchgrass, published by Christian Tobias, a molecular biologist at the ARS Western Regional Research Center in Albany, Calif., and his colleagues, is expected to speed up the search for genes that &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/a-new-tool-for-improving-switchgrass-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study Finds That The GRB7 Gene Drives An Aggressive Form Of Breast Cancer</title>
		<link>http://www.ipscelltherapy.net/study-finds-that-the-grb7-gene-drives-an-aggressive-form-of-breast-cancer-2/</link>
		<comments>http://www.ipscelltherapy.net/study-finds-that-the-grb7-gene-drives-an-aggressive-form-of-breast-cancer-2/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:16:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/study-finds-that-the-grb7-gene-drives-an-aggressive-form-of-breast-cancer-2/</guid>
		<description><![CDATA[Oregon Health &#38; Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth. Isolating the role of this gene could ultimately help fine-tune a patient&#8217;s treatment and enable physicians to provide [...]]]></description>
			<content:encoded><![CDATA[<p>Oregon Health &amp; Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth. Isolating the role of this gene could ultimately help fine-tune a patient&#8217;s treatment and enable physicians to provide a more accurate prognosis&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/study-finds-that-the-grb7-gene-drives-an-aggressive-form-of-breast-cancer-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study Finds Aggressive Treatment of Low-Risk Prostate Cancer</title>
		<link>http://www.ipscelltherapy.net/study-finds-aggressive-treatment-of-low-risk-prostate-cancer/</link>
		<comments>http://www.ipscelltherapy.net/study-finds-aggressive-treatment-of-low-risk-prostate-cancer/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:16:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/study-finds-aggressive-treatment-of-low-risk-prostate-cancer/</guid>
		<description><![CDATA[More than 75% of men with low-risk cancer received aggressive treatment.
]]></description>
			<content:encoded><![CDATA[<p>More than 75% of men with low-risk cancer received aggressive treatment.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/study-finds-aggressive-treatment-of-low-risk-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gentris Corp. Appoints Karen Weck, M.D., as Consulting Medical Director</title>
		<link>http://www.ipscelltherapy.net/gentris-corp-appoints-karen-weck-m-d-as-consulting-medical-director/</link>
		<comments>http://www.ipscelltherapy.net/gentris-corp-appoints-karen-weck-m-d-as-consulting-medical-director/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:16:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/gentris-corp-appoints-karen-weck-m-d-as-consulting-medical-director/</guid>
		<description><![CDATA[MORRISVILLE, N.C., July 26 &#8212; Gentris Corporation, a global leader in applied clinical pharmacogenom&#8230;
]]></description>
			<content:encoded><![CDATA[<p>MORRISVILLE, N.C., July 26 &#8212; Gentris Corporation, a global leader in applied clinical pharmacogenom&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/gentris-corp-appoints-karen-weck-m-d-as-consulting-medical-director/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DTC Company Reps Behaving Badly</title>
		<link>http://www.ipscelltherapy.net/dtc-company-reps-behaving-badly/</link>
		<comments>http://www.ipscelltherapy.net/dtc-company-reps-behaving-badly/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:16:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/dtc-company-reps-behaving-badly/</guid>
		<description><![CDATA[The US Government Accountability Office recently released its findings from a sting conducted on several companies that sell direct-to-consumer genetic tests, finding that the results of such tests are often &#8220;of little or no practical use.&#8221;
]]></description>
			<content:encoded><![CDATA[<p>The US Government Accountability Office recently released its findings from a sting conducted on several companies that sell direct-to-consumer genetic tests, finding that the results of such tests are often &#8220;of little or no practical use.&#8221;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/dtc-company-reps-behaving-badly/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NIDA Seeks Small Businesses with PGx Expertise to Guide Research on Rx Addiction</title>
		<link>http://www.ipscelltherapy.net/nida-seeks-small-businesses-with-pgx-expertise-to-guide-research-on-rx-addiction/</link>
		<comments>http://www.ipscelltherapy.net/nida-seeks-small-businesses-with-pgx-expertise-to-guide-research-on-rx-addiction/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:16:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/nida-seeks-small-businesses-with-pgx-expertise-to-guide-research-on-rx-addiction/</guid>
		<description><![CDATA[The National Institute on Drug Abuse has issued a notice to survey whether any small businesses have the expertise to provide pharmacogenetic research support services for studies on drug addiction.
]]></description>
			<content:encoded><![CDATA[<p>The National Institute on Drug Abuse has issued a notice to survey whether any small businesses have the expertise to provide pharmacogenetic research support services for studies on drug addiction.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/nida-seeks-small-businesses-with-pgx-expertise-to-guide-research-on-rx-addiction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Roche receives FDA 510(k) clearance for CoaguChek XS Pro point-of-care anticoagulation monitor</title>
		<link>http://www.ipscelltherapy.net/roche-receives-fda-510k-clearance-for-coaguchek-xs-pro-point-of-care-anticoagulation-monitor/</link>
		<comments>http://www.ipscelltherapy.net/roche-receives-fda-510k-clearance-for-coaguchek-xs-pro-point-of-care-anticoagulation-monitor/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:16:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/roche-receives-fda-510k-clearance-for-coaguchek-xs-pro-point-of-care-anticoagulation-monitor/</guid>
		<description><![CDATA[Roche Diagnostics announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CoaguChek® XS Pro system, a new point-of-care anticoagulation monitor with a built-in bar code reader that can automatically scan and capture operator and patient identification information.
]]></description>
			<content:encoded><![CDATA[<p>Roche Diagnostics announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CoaguChek® XS Pro system, a new point-of-care anticoagulation monitor with a built-in bar code reader that can automatically scan and capture operator and patient identification information.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/roche-receives-fda-510k-clearance-for-coaguchek-xs-pro-point-of-care-anticoagulation-monitor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>People in the News</title>
		<link>http://www.ipscelltherapy.net/people-in-the-news-8/</link>
		<comments>http://www.ipscelltherapy.net/people-in-the-news-8/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:16:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Molecular Genetics]]></category>

		<guid isPermaLink="false">http://www.ipscelltherapy.net/people-in-the-news-8/</guid>
		<description><![CDATA[Didier Hirsch has been named chief financial officer and senior vice president at Agilent Technologies . Hirsch has been acting CFO and VP of corporate controllership and tax at the company since April.
]]></description>
			<content:encoded><![CDATA[<p>Didier Hirsch has been named chief financial officer and senior vice president at Agilent Technologies . Hirsch has been acting CFO and VP of corporate controllership and tax at the company since April.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipscelltherapy.net/people-in-the-news-8/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
